192 related articles for article (PubMed ID: 18955135)
1. A 3D linear solvation energy model to quantify the affinity of flavonoid derivatives toward P-glycoprotein.
Boccard J; Bajot F; Di Pietro A; Rudaz S; Boumendjel A; Nicolle E; Carrupt PA
Eur J Pharm Sci; 2009 Feb; 36(2-3):254-64. PubMed ID: 18955135
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer resistance protein (BCRP/ABCG2): new inhibitors and QSAR studies by a 3D linear solvation energy approach.
Nicolle E; Boccard J; Guilet D; Dijoux-Franca MG; Zelefac F; Macalou S; Grosselin J; Schmidt J; Carrupt PA; Di Pietro A; Boumendjel A
Eur J Pharm Sci; 2009 Aug; 38(1):39-46. PubMed ID: 19501160
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in the discovery of flavonoids and analogs with high-affinity binding to P-glycoprotein responsible for cancer cell multidrug resistance.
Boumendjel A; Di Pietro A; Dumontet C; Barron D
Med Res Rev; 2002 Sep; 22(5):512-29. PubMed ID: 12210557
[TBL] [Abstract][Full Text] [Related]
4. In silico modelling of the interaction of flavonoids with human P-glycoprotein nucleotide-binding domain.
Badhan R; Penny J
Eur J Med Chem; 2006 Mar; 41(3):285-95. PubMed ID: 16494971
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationships of a series of tariquidar analogs as multidrug resistance modulators.
Globisch C; Pajeva IK; Wiese M
Bioorg Med Chem; 2006 Mar; 14(5):1588-98. PubMed ID: 16307883
[TBL] [Abstract][Full Text] [Related]
6. QSAR modeling of the interaction of flavonoids with GABA(A) receptor.
Duchowicz PR; Vitale MG; Castro EA; Autino JC; Romanelli GP; Bennardi DO
Eur J Med Chem; 2008 Aug; 43(8):1593-602. PubMed ID: 18158201
[TBL] [Abstract][Full Text] [Related]
7. A simplified model to predict P-glycoprotein interacting drugs from 3D molecular interaction field.
Zhuang XM; Xiao JH; Li JT; Zhang ZQ; Ruan JX
Int J Pharm; 2006 Feb; 309(1-2):109-14. PubMed ID: 16376035
[TBL] [Abstract][Full Text] [Related]
8. 3D-QSAR studies for the binding affinity toward (R, S)-2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)-propionic acid receptor.
Sharma RN; Thakar H; Vasu KK; Chaturvedi SC
Acta Pharm; 2008 Sep; 58(3):335-45. PubMed ID: 19103570
[TBL] [Abstract][Full Text] [Related]
9. Development of predictive in silico model for cyclosporine- and aureobasidin-based P-glycoprotein inhibitors employing receptor surface analysis.
Zalloum HM; Taha MO
J Mol Graph Model; 2008 Nov; 27(4):439-51. PubMed ID: 18789739
[TBL] [Abstract][Full Text] [Related]
10. 3D-pharmacophores of flavonoid binding at the benzodiazepine GABA(A) receptor site using 4D-QSAR analysis.
Hong X; Hopfinger AJ
J Chem Inf Comput Sci; 2003; 43(1):324-36. PubMed ID: 12546568
[TBL] [Abstract][Full Text] [Related]
11. Molecular factors influencing the affinity of flavonoid compounds on P-glycoprotein efflux transporter.
Vázquez RN; Camargo AB; Marchevsky EJ; Luco JM
Curr Comput Aided Drug Des; 2014; 10(3):250-8. PubMed ID: 25756670
[TBL] [Abstract][Full Text] [Related]
12. Prediction of the binding mode of biarylpropylsulfonamide allosteric AMPA receptor modulators based on docking, GRID molecular interaction fields and 3D-QSAR analysis.
Harpsøe K; Liljefors T; Balle T
J Mol Graph Model; 2008 Jan; 26(5):874-83. PubMed ID: 17644444
[TBL] [Abstract][Full Text] [Related]
13. Flavonoid dimers as bivalent modulators for p-glycoprotein-based multidrug resistance: structure-activity relationships.
Chan KF; Zhao Y; Chow TW; Yan CS; Ma DL; Burkett BA; Wong IL; Chow LM; Chan TH
ChemMedChem; 2009 Apr; 4(4):594-614. PubMed ID: 19288491
[TBL] [Abstract][Full Text] [Related]
14. Interaction of the P-glycoprotein multidrug efflux pump with cholesterol: effects on ATPase activity, drug binding and transport.
Eckford PD; Sharom FJ
Biochemistry; 2008 Dec; 47(51):13686-98. PubMed ID: 19049391
[TBL] [Abstract][Full Text] [Related]
15. 3D-QSAR studies on UDP-glucuronosyltransferase 2B7 substrates using the pharmacophore and VolSurf approaches.
Ako R; Dong D; Wu B
Xenobiotica; 2012 Sep; 42(9):891-900. PubMed ID: 22494439
[TBL] [Abstract][Full Text] [Related]
16. QSAR study of flavonoid derivatives as p56lck tyrosinkinase inhibitors.
Thakur A; Vishwakarma S; Thakur M
Bioorg Med Chem; 2004 Mar; 12(5):1209-14. PubMed ID: 14980632
[TBL] [Abstract][Full Text] [Related]
17. A pharmacophore hypothesis for P-glycoprotein substrate recognition using GRIND-based 3D-QSAR.
Cianchetta G; Singleton RW; Zhang M; Wildgoose M; Giesing D; Fravolini A; Cruciani G; Vaz RJ
J Med Chem; 2005 Apr; 48(8):2927-35. PubMed ID: 15828831
[TBL] [Abstract][Full Text] [Related]
18. QSAR studies on P-glycoprotein-regulated multidrug resistance and on its reversal by phenothiazines.
Dearden JC; Al-Noobi A; Scott AC; Thomson SA
SAR QSAR Environ Res; 2003; 14(5-6):447-54. PubMed ID: 14758987
[TBL] [Abstract][Full Text] [Related]
19. QSAR of aromatic substances: protein tyrosine kinase inhibitory activity of flavonoid analogues.
Deeb O; Clare BW
Chem Biol Drug Des; 2007 Nov; 70(5):437-49. PubMed ID: 17927721
[TBL] [Abstract][Full Text] [Related]
20. Combinatorial QSAR modeling of P-glycoprotein substrates.
de Cerqueira Lima P; Golbraikh A; Oloff S; Xiao Y; Tropsha A
J Chem Inf Model; 2006; 46(3):1245-54. PubMed ID: 16711744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
